ALBANY, New York, Jan. 15, 2018 -- Arterial stents are key components of percutaneous coronary intervention (PCI) procedures commonly known as angioplasty and makes for a market that is expanding with rising incidence of blockage in the coronary artery. To serve this, the global arterial stents market is witnessing the presence of several large and regional players, which makes the competitive landscape fragmented. A recent market study by Transparency Market Research (TMR) observes the concentration of small players in regional markets, although the market does witnesses the concentration of some key players globally. Some of these players are Abbott Laboratories, Boston Scientific Corporation, Medtronic, Cook Medical, Lifetech Scientific, and Gore Medical.
View Report Preview at https://www.transparencymarketresearch.com/arterial-stents-market.html
To outshine their competitors, key players are engaged in intensive clinical trials to launch novel products despite long haul for regulatory approvals. Key players are also seeking to use novel alloys such as Co-Cr and nitinol to manufacture improved products. Participation in industry events and association with healthcare professionals are also adding to the advantage of these players for marketing objectives.
As per the TMR report, the demand in the global market for arterial stents to rise at an impressive CAGR of 9.5% between 2017 and 2025. Progressing at this pace, the opportunities in the market will translate into a revenue of US$17.8 bn by the end of 2025. The global arterial stents market was valued at US$8.0 bn in 2016. Of the various product types, coronary stents accounted for the dominant market share in 2016. In terms of application, coronary artery led the market in 2016 vis-à-vis revenue due to the increasing incidence of On the basis of geography, Europe held the leading share in the overall market in 2016 vis-à-vis revenue.
Request to View Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=36146
Rising Burden of Coronary Artery Diseases Stokes Demand
Majorly fuelling the global arterial stents market is technological advancements and launch of novel products such as bioresorbable stents, along with rising incidence of coronary artery diseases and other arterial disorders. Rising demand for minimally invasive procedures and growing geriatric population globally susceptible to coronary artery diseases is stoking the demand for arterial stents.
Arterial stents refer to minute tube-shaped devices that are inserted in the artery during a surgical procedure commonly known as angioplasty. The arterial stents are permanently inserted in the arteries to prop open an artery and improve blood flow. Arterial stents help keep coronary arteries open and reduce the chance of a heart attack.
Download PDF Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=36146
Proven effectiveness of arterial stents for peripheral and coronary artery diseases, and increasing use of newer materials such as Co-Cr and nitinol leading to the manufacture of improved products are some other key factors acting in favor of arterial stents market. Furthermore, favorable reimbursement policies for percutaneous coronary intervention procedures and availability of these procedures at state run, charitable hospitals is also stoking the demand for arterial stents.
Strict Product Approval Process and Product Recalls Crimps Growth
On the downside, substantial efforts from private and public enterprises for the development of venous stents is likely to hamper the demand for arterial stents. Furthermore, dearth of trained interventional cardiologists in developing and under-developed countries and increasing preference for bypass surgery for cardiovascular disorders are slowing the growth of arterial stents market. Strict process for product approval, and numerous cases of product recall and product failure could hamper the growth of this market in the upcoming years.
Buy Arterial Stents Market Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=36146<ype=S
About TMR
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Nachiket Ghumare Transparency Market Research State Tower 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com TMR Blog: http://www.tmrblog.com/


Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Anta Sports Expands Global Footprint With Strategic Puma Stake
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Washington Post Publisher Will Lewis Steps Down After Layoffs
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



